Solomon I, Amann M, Goubier A, Arce Vargas F, Zervas D, Qing C, et al
Glaeser, D
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was financially supported by the National Natural Science Foundation of China (82003755) and the Initial Scientific Research Foundation for Youth of Jinhua Municipal Central Hospital (JY2019-2-01)
156,159 As mentioned above, TP53 mutations not only lose the ability to suppress tumorigenesis but also promote cancer development
Drug design at peptide receptors: somatostatin receptor ligands
at The BEST Program offers personalized vitamin therapy in the Miami - Fort Lauderdale - Port St